Clinical and Life Sciences · 30 September 2026 to 30 September 2026 · 1 headlines · STAT
STAT Plus: Three biotech updates, including accusations of theft and and a new lobbying leader
STAT News published a roundup of three biotech updates, including a case involving accusations of theft and news of a new leader for a biotech lobbying group.
As it ran
30 September 2026
More from US healthcare
- STAT Plus: What health tech leaders are talking about in Washington policy circles 30 September 2026
- STAT Plus: Eli Lilly’s Zepbound combined with amylin drug led to significant weight loss in mid-stage trial 30 September 2026
- America’s biotech race with China must be won at home 30 September 2026
- CAR-T Therapy Shows Durable Benefits in Myasthenia Gravis 30 September 2026
- Drugs Are Widely Used To Sedate Dementia Patients. Her Sons Wanted To Keep Her Off Them. 30 September 2026
- HOPDs' higher drug payment rates drive $12.7B in spending: EBRI 30 September 2026
- T cell brain barrier research 30 September 2026
- Vaccine and drug policy in the midterm elections 29 September 2026